Algemeen Ziekenhuis Maria Middelares

Ghent, Oost-Vlaanderen 9000

0 studies enrolling now · 3 studies all time

What they study most

Cirrhosis, Liver, NASH, NASH - Nonalcoholic Steatohepatitis, Nonalcoholic Steatohepatitis

Studies at this site

• A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES) — Running, not enrolling
• A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis — Running, not enrolling
• AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH) — Stopped early